Such observations imply that APOE plays an important role in SARS-CoV-2 infection, while APOE has been identified as a clinical trial drug target for familial hypercholesterolemia and hyperlipidemia as of the TTD database (44) (https://db.idrblab.net/ttd). Here, APOE is linked to familial hypercholesterolemia.